Biogen
BIIB
BIIB
1,083 hedge funds and large institutions have $40.6B invested in Biogen in 2019 Q1 according to their latest regulatory filings, with 118 funds opening new positions, 389 increasing their positions, 437 reducing their positions, and 164 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,083
Holders Change
-57
Holders Change %
-5%
% of All Funds
23.48%
Holding in Top 10
22
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-24.14%
% of All Funds
0.48%
New
118
Increased
389
Reduced
437
Closed
164
Calls
$1.15B
Puts
$1.28B
Net Calls
-$132M
Net Calls Change
+$215M
Top Buyers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$250M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$210M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$206M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$177M |
| 5 |
D.E. Shaw & Co
New York
|
+$154M |
Top Sellers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$382M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$265M |
| 3 |
JPMorgan Chase & Co
New York
|
-$208M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$192M |
| 5 |
O
OrbiMed
New York
|
-$177M |
